牛蒡子中天然有效成分对缓解肝纤维化的 作用及机制的研究进展
Research Progress on the Effects and Mechanisms of Natural Active Components in Arctium lappa L. on Alleviating Hepatic Fibrosis
DOI: 10.12677/acm.2026.1631150, PDF,    科研立项经费支持
作者: 谭海霞, 陈 鹏*, 王 丽, 周千钰, 张仁安:昆明医科大学第二附属医院,肝胆外科四病区,云南 昆明
关键词: 肝纤维化天然药物牛蒡苷牛蒡子苷元牛蒡子研究进展Hepatic Fibrosis Natural Medicine Arctiin Arctigenin Arctium lappa L. Research Progress
摘要: 肝纤维化(Hepatic Fibrosis, HF)是指肝脏对急性或慢性肝损伤的一种常见反应,与高发病率和死亡率密切相关。细胞外基质(ECM)在慢性肝损伤过程中会持续沉积,最终会替代正常肝细胞而形成纤维化。目前暂无治疗肝纤维化的特效药,但有报道证明其存在逆转的可能。牛蒡子是一种药食同源的植物,源于菊科草本植物牛蒡的干燥成熟果实。多个报道说明从牛蒡根中提取的主要天然药理活性成分包括牛蒡苷(Arctiin, ARC)、牛蒡子苷元(Arctigenin, ARC-G)及多糖类等具有抑制肿瘤细胞活性、抗菌、抗病毒、抗氧化应激反应、抗炎等一系列生物活性。且牛蒡子类天然药物已经在其他体外实验及体内机体组织中表现出抗纤维化活性。本文对牛蒡子中有效天然成分缓解肝纤维化的研究进行综述,以期为临床应用牛蒡子中天然有效成分对治疗肝纤维化提供依据和参考。
Abstract: Hepatic fibrosis (HF) is a common pathological response of the liver to acute or chronic liver injury, and it is closely associated with high morbidity and mortality rates. During chronic liver injury, the excessive deposition of the extracellular matrix (ECM) ultimately replaces normal hepatocytes, leading to the formation of fibrosis. At present, there is no specific drug for the treatment of hepatic fibrosis, but several studies have demonstrated the possibility of its reversal. Arctium lappa L. is a plant with both medicinal and edible values, and its dried ripe fruits are the medicinal part of this herbaceous plant belonging to the genus Arctium of the Asteraceae family. Arctiin (ARC), arctigenin (ARC-G) and polysaccharides are the main pharmacologically active components in Arctium lappa L., which exhibit a series of biological activities including antiproliferation, anti-inflammation, antioxidation, antivirus and antitumor effects. Moreover, natural medicines derived from Arctium lappa L. have been shown to possess antifibrotic activity in other in vitro experiments and in vivo tissues. This paper reviews the research progress on the alleviatory effects of natural active components from Arctium lappa L. on hepatic fibrosis, aiming to provide evidence and references for the clinical application of these components in the treatment of hepatic fibrosis.
文章引用:谭海霞, 陈鹏, 王丽, 周千钰, 张仁安. 牛蒡子中天然有效成分对缓解肝纤维化的 作用及机制的研究进展[J]. 临床医学进展, 2026, 16(3): 3442-3448. https://doi.org/10.12677/acm.2026.1631150

参考文献

[1] Friedman, S.L. and Pinzani, M. (2022) Hepatic Fibrosis 2022: Unmet Needs and a Blueprint for the Future. Hepatology, 75, 473-488. [Google Scholar] [CrossRef] [PubMed]
[2] Devarbhavi, H., Asrani, S.K., Arab, J.P., Nartey, Y.A., Pose, E. and Kamath, P.S. (2023) Global Burden of Liver Disease: 2023 Update. Journal of Hepatology, 79, 516-537. [Google Scholar] [CrossRef] [PubMed]
[3] GBD 2013 Risk Factors Collaborators and Murray, C.J. (2015) Global, Regional, and National Comparative Risk Assessment of 79 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks in 188 Countries, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 386, 2287-2323.
[4] Tsochatzis, E.A., Bosch, J. and Burroughs, A.K. (2014) Liver Cirrhosis. The Lancet, 383, 1749-1761. [Google Scholar] [CrossRef] [PubMed]
[5] Park, S.H., Lee, Y., Sim, J., Seo, S. and Seo, W. (2022) Alcoholic Liver Disease: A New Insight into the Pathogenesis of Liver Disease. Archives of Pharmacal Research, 45, 447-459. [Google Scholar] [CrossRef] [PubMed]
[6] Khanam, A., Saleeb, P.G. and Kottilil, S. (2021) Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells, 10, Article 1097. [Google Scholar] [CrossRef] [PubMed]
[7] Roehlen, N., Crouchet, E. and Baumert, T.F. (2020) Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9, Article 875. [Google Scholar] [CrossRef] [PubMed]
[8] 蔡恩博, 王瑞卿, 刘德民, 等. 牛蒡子苷元现代药理作用研究进展[J]. 世界科学技术-中医药现代化, 2016, 18(1): 130-134.
[9] 王俊. 牛蒡子苷元干预肾脏间质纤维化的作用机制研究[D]: [硕士学位论文]. 重庆: 重庆理工大学, 2015.
[10] 王悦尚. 牛蒡子苷元基于抗氧化及抗炎抑制肺纤维化的作用机制研究[D]: [博士学位论文]. 武汉: 华中农业大学, 2023.
[11] 武鸣凤. 肝功能结合血生化指标检测诊断慢性乙肝肝硬化的价值[J]. 中国典型病例大全, 2025, 19(3): 212-216.
[12] 关辉, 章勇. 慢性乙型病毒性肝炎患者血清转化生长因子-β1水平与肝脏纤维化程度的关系[J]. 吉林医学, 2025, 46(12): 2987-2991.
[13] 程小艳. 牛蒡苷对T.g.HSP70诱导弓形虫感染小鼠急性肝损伤的保护作用及机制[D]: [硕士学位论文]. 延吉: 延边大学, 2016.
[14] 付兴芹, 张惠, 张青青, 等. 牛蒡子苷元对ConA诱导小鼠急性肝炎的保护作用[J]. 青岛大学学报(医学版), 2018, 54(3): 268-272.
[15] 华慧, 陈渝萍. 天然中草药及其提取物通过对肝星状细胞的抗氧化实现抗肝纤维化[J]. 中国药物经济学, 2024, 19(7): 108-112.
[16] 顾晓明, 张圆, 张晓卫, 等. 牛蒡的化学成分及药理作用研究进展[J]. 现代生物医学进展, 2013, 13(16): 3179-3182.
[17] 黄栋栋, 蔡志毅. 牛蒡子苷元抗肿瘤分子机制研究进展[J]. 检验医学, 2016, 31(6): 546-548.
[18] 张明月, 周露露, 徐翔, 等. 牛蒡中有效成分对肝脏保护作用的研究进展[J]. 华西药学杂志, 2017, 32(6): 661-663.
[19] 李影, 俞浩辉, 陈格尔, 等. IL-27通过调节巨噬细胞极化状态治疗急性胰腺炎的实验研究[J]. 肝胆胰外科杂志, 2025, 37(12): 822-831.
[20] Wang, M.J., Zhang, H.L., Chen, F., Guo, X.J., Liu, Q.G. and Hou, J. (2024) The Double-Edged Effects of IL-6 in Liver Regeneration, Aging, Inflammation, and Diseases. Experimental Hematology & Oncology, 13, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, W.M., Xu, X.S. and Miao, C.M. (2020) Kupffer Cell‐Derived TNF‐α Triggers the Apoptosis of Hepatic Stellate Cells through TNF‐r1/Caspase 8 Due to ER Stress. BioMed Research International, 2020, Article 8035671. [Google Scholar] [CrossRef] [PubMed]
[22] 周玉燕, 陆萧雅, 夏丽, 等. 牛蒡子苷通过抑制炎症通路降低雷公藤甲素所致肾毒性[J]. 南方医科大学学报, 2020, 40(10): 1399-1405.
[23] 冯芹. 小鼠急性肝损伤及牛蒡子苷元保护作用的研究[D]: [博士学位论文]. 南京: 南京大学, 2018.
[24] 董晓辉, 王贝, 王晨莹, 等. 牛蒡子苷元对脂多糖诱导小鼠肝损伤的保护作用机制研究[J]. 中国临床药理学杂志, 2020, 36(13): 1815-1817+1829.
[25] Berumen, J., Baglieri, J., Kisseleva, T. and Mekeel, K. (2020) Liver Fibrosis: Pathophysiology and Clinical Implications. WIREs Mechanisms of Disease, 13, e1499. [Google Scholar] [CrossRef] [PubMed]
[26] 杨建展, 吴烦, 沈东宁, 等. 萜类成分抗肝纤维化作用及其机制研究进展[J/OL]. 中草药: 1-14.
https://link.cnki.net/urlid/12.1108.R.20251205.1409.002, 2026-01-28.
[27] Zhang, X., Li, M., Zuo, K., Li, D., Ye, M., Ding, L., et al. (2013) Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/β-Catenin Signaling. The Journal of Clinical Endocrinology & Metabolism, 98, E1305-E1313. [Google Scholar] [CrossRef] [PubMed]
[28] 张晓珣, 王俊, 赵宇, 等. 牛蒡子苷元对四氯化碳致大鼠肝纤维化的治疗作用[J]. 中国药理学与毒理学杂志, 2016, 30(1): 53-60.
[29] 马丽娜, 王伟, 汪丽云. 炎症和脂代谢紊乱在肝纤维化中的作用机制[J]. 华中科技大学学报(医学版), 2025, 54(6): 908-915.
[30] 张峥, 梁悦, 唐恩琪, 等. 扶正化瘀方抗小鼠胆汁淤积性肝纤维化的作用机制[J]. 中华肝脏病杂志, 2025, 33(9): 889-897.
[31] 张晓珣. 牛蒡子苷元抗肝纤维化作用及抑制肝星状细胞增殖的分子机制研究[D]: [硕士学位论文]. 重庆: 重庆理工大学, 2016.
[32] 重庆理工大学. 牛蒡子苷元在制备治疗肝纤维化或肝硬化药物中的应用[P]. 中国专利, 201410367239.2. 2014-10-15.
[33] Cai, E., Song, X., Han, M., Yang, L., Zhao, Y., Li, W., et al. (2018) Experimental Study of the Anti-Tumour Activity and Pharmacokinetics of Arctigenin and Its Valine Ester Derivative. Scientific Reports, 8, Article No. 3307. [Google Scholar] [CrossRef] [PubMed]
[34] 袁媛. 牛蒡子质量控制方法及其水提物药代动力学和药效动力学研究[D]: [博士学位论文]. 沈阳: 辽宁中医药大学, 2009.
[35] 刘富铭. 毛头牛蒡子中总木脂素有效部位与药动学研究[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2020.